GSTM1 and acute myeloid leukemia: AML with biallelic mutations of CCAAT enhancer binding protein alpha (CEBPA) was typically associated with a normal Hb level, normal karyotype, and higher blast cell count with a good response to induction chemotherapy (9,19,24,25).